Log in to search using one of your social media accounts:

 

7 medtech stories we missed this week: August 4, 2017
[Image from unsplash.com]From MDCorp inking a European distribution deal to Align Technology’s North Carolina expansion, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. MDCorp inks distribution deal with Smart Endoscope Systems MDCorp announced in a July 31 press release that it has signed a distribution agreement with Smart Endoscope Systems, giving MDCorp permission to sell Smart’s G-Eye system throughout its European market. Neuraxon, which is in the process of merging with MDCorp, is going to be responsible for distributing the G-Eye system in Europe and a netw...
Source: Mass Device - August 4, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Food & Drug Administration (FDA) Imaging Ultrasound Vascular Weight loss Access Scientific Inc. aligntechnology Central California Blood Center Cerus Corp. FujiFilm Medical Systems MDCorp MedTech Smart Endoscope Systems Standard Source Type: news

Cathflo Activase (Alteplase Powder for Reconstitution for Use in Central Venous Access Devices) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 12, 2017 Category: Drugs & Pharmacology Source Type: news

Bio2 touts pivotal data on Angel catheter-filter combo
This study of a combined IVC filter/central venous catheter was the culmination of a panel of dedicated investigators with careful guidance by the FDA,” primary investigator Dr. Victor Tapson said in prepared remarks. “The efficacy and safety of the device, simple bedside placement, and the need to remove it before discharge make it very appealing. Nearly the entire cohort had crucial, yet short-term filter needs so that discharge without a filter was preferred.” The device is the 1st to be cleared by the FDA for PE prophylaxis in critically ill patients contraindicated to anticoagulation. “The publ...
Source: Mass Device - June 30, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Catheters Clinical Trials Vascular BiO2 Medical Source Type: news

Baxter touts HDx Theranova data for ‘ extended ’ hemodialysis
Baxter (NYSE:BAX) today released data from 2 independent studies of its novel HDx therapy using the Theranova dialyzer, touting the effective removal of small and mid-sized toxins at similar rates compared to hemodiafiltration. Results from the trial were presented at the 54th Congress of the European Renal Association and European Dialysis and Transplant Association this week, the company said. The Deerfield, Ill.-based company’s HDx therapy uses a Theranova dialyzer designed to extend the range of molecules that it filters from the blood, claiming it “more closely mimics the natural kidney,” accord...
Source: Mass Device - June 5, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Clinical Trials Baxter Source Type: news

Bio2 Medical raises $1.5m, looking for $6.5m more
Bio2 Medical raised $1.5 million in a new round of debt and option financing, according to an SEC filing posted this week. Money in the round came from 1 unnamed investor, with the date of the sale noted as March 18, according to the filing. The company has not yet stated how it plans to spend funds raised during the offering. Bio2 is looking to raise an additional $6.5 million before closing the round. A portion of the proceeds from the round will be used to pay the salaries of certain company officers, according to the filing. Last August, Bio2 Medical pulled in $3 million from a 2nd tranche of financing from O...
Source: Mass Device - March 31, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Catheters BiO2 Medical Source Type: news

MassDevice.com +5 | The top 5 medtech stories for March 6, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Via Surgical inks distro deal with Progressive Medical for FasTouch Via Surgical said today it inked an exclusive US distribution deal with Progressive Medical to distribute Via’s FasTouch soft tissue suture device. Amiri...
Source: Mass Device - March 6, 2017 Category: Medical Equipment Authors: MassDevice Tags: Blog News Well Plus 5 Source Type: news

Merit Medical backs Bluegrass Vascular ’ s Surfacer ‘ inside-out ’ catheter
Bluegrass Vascular Technologies said today that it entered a “strategic relationship” with Merit Medical (NSDQ:MMSI) for its Surfacer “inside-out” catheter that includes an equity stake and a distribution agreement. The Surfacer device is designed to provide access to the jugular vein to restore central venous access in hemodialysis patients with blocked neck veins; it won CE Mark approval in the European Union last August. The catheter is threaded through the femoral vein up to and into blockage in the jugular, which acts as a stabilizer. The head of the catheter is then al...
Source: Mass Device - March 6, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Distribution Funding Roundup Vascular Wall Street Beat Bluegrass Vascular Technologies Merit Medical Systems Inc. Source Type: news

Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults
This Cochrane Review informed a practice changing update on Dynamed Plus. It found that antimicrobial coatings that appear to reduce risk of central venous catheter-related bloodstream infection include minocycline-rifampicin, chlorhexidine silver sulfadiazine, silver, and heparin, but antimicrobial coatings do not appear to reduce risk of sepsis or mortality (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 2, 2016 Category: Consumer Health News Source Type: news

Staphylococcus saprophyticus Bacteremia in a Pediatric Patient with Central Venous Catheter-Associated Infection
We report a case of S. saprophyticus central venous catheter (CVC)-associated bacteremia identified by matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF) mass spectrometry and provide a review of how to report and interpret antimicrobial susceptibility results for coagulase-negative staphylococci (CoNS) when species identification is warranted. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - September 21, 2016 Category: Microbiology Authors: Peera Hemarajata, Kristina Adachi, Lynn Ramirez-Avila, Romney M. Humphries Source Type: news

FDA nod for Angel catheter triggers $3m tranche for Bio2 Medical
The 510(k) clearance Bio2 Medical won from the FDA in July for its Angel catheter triggered a 2nd, $3 million tranche from Oxford Finance last week, the company said yesterday. The Angel catheter is designed to provide access to the central venous system and to trap blood clots before they can reach the lungs, according to the Golden, Colo.-based company. The FDA cleared the device July 28, Bio2 said August 24. Bio2 said it plans to use the funds to commercialize the Angel device in the U.S. by hiring sales reps, building up inventory and working on market development. The tranche is part of an $8 million secured...
Source: Mass Device - August 31, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Catheters Funding Roundup Wall Street Beat BiO2 Medical Source Type: news

MassDevice.com +5 | The top 5 medtech stories for August 30, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Vention Medical boosts footprint in Ireland Vention Medical said today that it boosted its footprint on the Emerald Isle with the opening of a new facility on the National University of Ireland’s Galway campus. Read ...
Source: Mass Device - August 30, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Bluegrass Vascular wins CE Mark for Surfacer vascular access device
Bluegrass Vascular Technologies said today that it won CE Mark approval in the European Union for its Surfacer vascular access device and plans a limited commercial launch in 7 countries there. Surfacer is designed to restore central venous access in patients with occluded veins. San Antonio-based Bluegrass Vascular, which drummed up a $4.5 million Series A round 2 years ago to back its CE Mark bid, said it plans to put Surfacer on the market in the U.K., Germany, Austria, Italy, Holland, Belgium and Luxembourg. The company said it’s also set to begin a post-market registry study of the device. &l...
Source: Mass Device - August 30, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Regulatory/Compliance Vascular Bluegrass Vascular Technologies Source Type: news

Skin antisepsis for reducing central venous catheter-related infections
This review concludes that it is not clear whether cleaning skin around CVC insertion sites with antiseptic reduces catheter related blood stream infection vs. no skin cleansing. Very low quality evidence suggests chlorhexidine may reduce rates of infection and catheter colonisation vs. povidone iodine. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 24, 2016 Category: Consumer Health News Source Type: news

NIH announces winners of undergraduate biomedical engineering design competition
(NIH/National Institute of Biomedical Imaging& Bioengineering) In a nation-wide competition, six teams of undergraduate engineering students produced prize-winning designs for technological advances to improve human health. The Design by Biomedical Undergraduate Teams (DEBUT) Challenge winning teams designed tools for a myriad of health care challenges, including diagnosing tuberculosis (TB) in children and a safer alternative for central venous catheter placements. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 23, 2016 Category: Cancer & Oncology Source Type: news

Lungpacer Medical hits the FDA fast track with phrenic nerve pacer
Lungpacer Medical said it won an expedited access pathway designation from the FDA for the diaphragm pacing system it’s developing to treat patients who can’t be weaned from mechanical ventilation. The Lungpacer DPS device is a neurostimulation system designed to exercise and strengthen the diaphragm via the temporary, transcatheter stimulation of the phrenic nerve. The FDA’s EAP designation is for breakthrough therapies aimed at unmet clinical needs and seeks lower the cost and amount of time it takes to get the treatment to market. “Our team is thrilled that the Lungpacer DPS was granted EAP ...
Source: Mass Device - May 11, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Neuromodulation/Neurostimulation Regulatory/Compliance Respiratory Expedited Access Program (EAP) Lungpacer Medical Source Type: news

MassDevice.com +5 | The top 5 medtech stories for April 29, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Hill-Rom slides on Q2 revenues miss Hill-Rom shares took a hit today after the company reported that fiscal 2nd-quarter sales missed expectations despite the contribution of new acquisition Welch Allyn. Chicago-based Hill-Rom s...
Source: Mass Device - April 29, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Merit Medical looks to capitalize on rival Cook’s recall
Merit Medical (NSDQ:MMSI) chief Fred Lampropoulos said his company is ready to take advantage of the worldwide recall of rival Cook Medical‘s central catheter sets. The FDA in March slapped the Cook recall with a Class I label, denoting the risk of serious injury or death. It covers Cook’s single lumen central venous catheter sets and trays, single lumen pressure monitoring sets and trays, femoral artery pressure monitoring catheter sets and trays and radial artery pressure monitoring catheter sets and trays. During a conference call with analysts yesterday discussing Merit’s 1st-quart...
Source: Mass Device - April 29, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Catheters Food & Drug Administration (FDA) MassDevice Earnings Roundup Recalls Regulatory/Compliance Cook Medical Merit Medical Systems Inc. Source Type: news

FDA releases February 2016 510(k) clearances
February 2016 510(k) Clearances 510(k) summaries or 510(k) statements for final decisions rendered during the period February 2016. TOTAL 510(k)s THIS PERIOD 224 TOTAL WITH SUMMARIES 213 TOTAL WITH STATEMENTS 11 February 2016 510(k) Clearances 510(K) SUMMARIES OR 510(K) STATEMENTS FOR FINAL DECISIONS RENDERED DURING THE PERIOD February 2016 DEVICE: ANI Monitor MDOLORIS MEDICAL SYSTEMS SAS 510(k) NO: K142969(Traditional) ATTN: MATHILDE COLLET PHONE NO : 011 333 62092081 6, RUE DU PR LAGUESSE SE DECISION MADE: 23-FEB-16 LILLE FR 59037 510(k) SUMMARY AVAILABLE FROM FDA DEVICE: DBSWIN and VistaEasy Imaging Software Durr Dental...
Source: Mass Device - April 5, 2016 Category: Medical Equipment Authors: MassDevice Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news

FDA: Cook Medical central venous cath recall is Class I
The FDA today labeled Cook Medical‘s recall of its central venous catheter and pressure monitoring sets and trays as Class I over issues with tip splitting and separation. The devices being recalled are used to monitor pressure in a patient’s vein or artery, to sample blood and to administer drugs or fluids. Class I recall designations, the FDA’s most serious classification of recall, are used when there is a reasonable probability that product use could cause serious adverse health consequences or death. The devices are being recalled over issues with device tips splitting or separating from the catheter...
Source: Mass Device - March 30, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Food & Drug Administration (FDA) Recalls Cook Medical Source Type: news

Class I Medical Device Recall: Cook Medical Recalls Central Venous Catheter and Pressure Monitoring Sets and Trays due to Tips that May Split or Separate
Cook Medical is recalling these devices because the tips may split or separate from the catheters due to a manufacturing error. If this occurs, the tip could enter the patient’s bloodstream. (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - March 30, 2016 Category: Medical Equipment Source Type: news

Antibiotic-Impregnated Catheters and Risk for Infections in KidsAntibiotic-Impregnated Catheters and Risk for Infections in Kids
Antibiotic-impregnated central venous catheters may reduce the risk of pediatric bloodstream infections better than heparin-impregnated or standard central venous catheters, according to research from the United Kingdom. Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - March 23, 2016 Category: Intensive Care Tags: Pediatrics News Source Type: news

Frequency of dressing changes for central venous access devices on catheter-related infections
The review set out to assess the effect of the frequency of CVAD dressing changes on the incidence of CRIs and other outcomes including pain and skin damage. The review concludes that in the absence of clear evidence of an increased risk associated with extending the time between dressing changes, it is reasonable to base decisions on patient preference and cost. CVAD sites should be inspected on a daily basis to ensure dressings are clean and intact with no signs of localised infection. Clinically indicated dressing changes should occur if the dressing is soiled or not intact. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 1, 2016 Category: Consumer Health News Source Type: news

Versago raises $1.7m for ‘reverse needle’ access port
Versago Vascular Access said today it received $1.7 million in seed funding from Primo Medical Group’s network of investors to support its “reverse needle” subcutaneous access port. West Bridgewater, Mass.-based Versago, a spinoff of Primo Medical Group, has designed and developed a subcutaneous port to access the body’s bloodstream and anatomical cavities that collect serous or ascitic fluid, according to the company. “No one could have ever imagined that subcutaneous port access could be simplified by having the needle advance out of the port body instead of into the body of the port. This w...
Source: Mass Device - February 26, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Implants Vascular Primo Medical Group Versago Vascular Access Source Type: news

Cook Medical recalls select single lumen caths
Cook Medical is recalling 360 lots of its single lumen central venous catheters, pressure monitoring sets and trays due to issues with catheter tip fracture and separation. A total of 17,872 devices are subject to the recall, according to Cook, who said it began notifying customers and distributors of the issue in January and that it has contacted the FDA and other regulatory bodies over the issue. The problem was discovered during an internal inspection, in which a catheter “exhibited the potential for catheter tip fracture and/or separation,” according to an FDA press release. Cook Medical said they investiga...
Source: Mass Device - February 11, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Food & Drug Administration (FDA) Recalls Vascular Cook Medical Source Type: news

Cook Medical Issues Global Recall of Select Lots of Central Venous Catheters and Pressure Monitoring Sets and Trays
On January 6, 2016, Cook Medical initiated a voluntary recall of 360 specific lots of Single Lumen Central Venous Catheters and Pressure Monitoring Sets and Trays due to catheter tip fracture and/or separation. Globally, 17,827 devices are subject to this recall. (Source: Food and Drug Administration)
Source: Food and Drug Administration - February 11, 2016 Category: Food Science Source Type: news

BiO2 Medical drums up $8m from Oxford Finance
Oxford Finance said yesterday it closed an $8 million secured term loan with Angel catheter maker BiO2 Medical, with funds slated to support FDA clearance and an anticipated commercial launch of the catheter in mid-2016. The Angel catheter is designed to provide access to the central venous system and to trap blood clots before they can reach the lungs, according to the San Antonio, Texas-based company. “With this equity and venture debt capital secured, we are on the path to commercializing the Angel Catheter in the U.S. We anticipate providing pulmonary embolism prophylaxis to over one million patients who are...
Source: Mass Device - January 29, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Blood Management Business/Financial News Catheters BiO2 Medical Source Type: news

Central Venous Catheter Intravascular MalpositioningCentral Venous Catheter Intravascular Malpositioning
Find out the best ways to prevent, identify, and correct the unintended placement of CVCs. Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 22, 2016 Category: Consumer Health News Tags: Emergency Medicine Journal Article Source Type: news

Best Central Venous Catheter Location?Best Central Venous Catheter Location?
Which vein is associated with the fewest central venous catheter complications? Medscape Critical Care (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 7, 2016 Category: Surgery Tags: Critical Care Viewpoint Source Type: news

BiO2 Med miracle: Angel cath pivotal trial ends 1 year early
BiO2 Medical said today the pivotal clincial trial of its Angel catheter hit its target of 150 evaluable patients and has concluded a solid year earlier than anticipated. The Angel catheter is designed to provide access to the central venous system and to trap blood clots before they can reach the lungs, according to the San Antonio, Texas-based company. “We are very excited about completing this pivotal U.S. trial.  We have found that physicians are very enthusiastic about an IVC filter that can be placed at the bedside in patients at very high risk for acute DVT / PE, or those with VTE who temporarily cannot b...
Source: Mass Device - December 21, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Clinical Trials BiO2 Medical Source Type: news

Fewer Complications With Subclavian CatheterizationFewer Complications With Subclavian Catheterization
Central venous catheterization of the subclavian vein showed the lowest risks for bloodstream infections and symptomatic thrombosis compared with insertions at the jugular or femoral veins. Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 25, 2015 Category: Intensive Care Tags: Critical Care News Source Type: news

Central Venous Catheter Insertion: Is the Subclavian Vein the Safest Option? (FREE)
By Amy Orciari Herman Edited by Susan Sadoughi, MD Catheterization of the subclavian vein is associated with lower risk for major catheter-related complications than insertion at the femoral or jugular vein, according to a New England Journal of Medicine study.Among adults … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 24, 2015 Category: Primary Care Source Type: news

Peripherally inserted central catheters can cause blood clots in lower limbs
Peripherally inserted central catheters (PICCs) are frequently used by healthcare professionals to obtain long-term central venous access in hospitalized patients. While there are numerous benefits associated with PICCs, a potential complication is deep vein thrombosis (DVT), or blood clots, in upper limbs. A new study of more than 70,000 patients in hospitals indicates that PICC use is associated not only with upper-extremity DVT, but also with lower-extremity DVT. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 17, 2015 Category: Science Source Type: news

Peripherally inserted central catheters can cause blood clots in lower limbs
(Elsevier Health Sciences) Peripherally inserted central catheters (PICCs) are frequently used by healthcare professionals to obtain long-term central venous access in hospitalized patients. While there are numerous benefits associated with PICCs, a potential complication is deep vein thrombosis (DVT), or blood clots, in upper limbs. A new study of more than 70,000 patients in 48 Michigan hospitals indicates that PICC use is associated not only with upper-extremity DVT, but also with lower-extremity DVT. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 17, 2015 Category: Global & Universal Source Type: news

Teleflex updates on Q2 earnings, FDA clearances, acquisitions, deals & study data.
This study, when combined with the 2 earlier independent studies by the same team, shows that using an Arrow CVC with antimicrobial protection from Teleflex makes sense from many perspectives. This study is further evidence that using an unprotected catheter may put both patients and a hospital’s bottom line at unnecessary risk. The Arrow CVC with Arrow+ard Technology has been repeatedly shown to improve patient safety even when the risk of infection is low, and it more than pays for itself in the process,” vascular access division prez Jay White said in a prepared statement. The Arrow catheter a...
Source: Mass Device - July 30, 2015 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Business/Financial News Cardiovascular Catheters Food & Drug Administration (FDA) MassDevice Earnings Roundup Mergers & Acquisitions Regulatory/Compliance Surgical Teleflex Source Type: news

BiO2 Medical raises $4m of $10m round
BiO2 Medical, developer of the Angel Catheter prophylactic pulmonary embolism protection device, said it raised $4 million, according to a regulatory filing. The Angel catheter is designed to provide access to the central venous system and to trap blood clots before they can reach the lungs, according to the San Antonio, Texas-based company. BiO2 Medical received $4 million of a hoped-for $10 million from 1 unnamed investor, according to an SEC filing. In January, BiO2 won a nod from the FDA for a 182-patient pivotal trial of the device in patients at high risk for developing pulmonary embolism who can’t take standar...
Source: Mass Device - July 13, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Catheters BiO2 Medical Source Type: news

PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This weeks topics include persistent banned substances in supplements, knowledge of central venous catheters among physicians, vitamin D levels and different types of milk, and MD- versus hospital-owned practices and costs. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - October 25, 2014 Category: Primary Care Source Type: news

Healthcare Workers Often Unaware of Whether Patients Have Central Venous Catheters (FREE)
By Kelly Young Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD Approximately one in five healthcare workers may not be able to recall whether their patients have central venous catheters (CVCs), according … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 21, 2014 Category: Primary Care Source Type: news

Bluegrass Vascular taps ex-ArthoCare R&D chief Niederauer for CEO | Personnel Moves
Bluegrass Vascular Technologies taps former ArthroCare R&D chief Gabriele Niederauer to be its new president & CEO. Bluegrass Vascular Technologies said it named Gabriele Niederauer its new president & CEO, hard on the heels of a Series A funding round that brought in $4.5 million for its Surfacer central venous catheter. ArthroCare Corp., Biolase Technology Inc., Bluegrass Vascular Technologies, Bovie Medical Corp., Copan Group, European Society of Cardiology, Evaluate Ltd., LED Medical Diagnostics Inc., Medina Medical, Novadaq, Philips Healthcare, Smith & Nephew, TYRX Inc.News Well, Personnel ...
Source: Mass Device - September 3, 2014 Category: Medical Equipment Authors: Brad Perriello Source Type: news

A bumpy start ends on a high note for newborn August Koch
Bringing your newborn baby home from the hospital is a happy and momentous occasion. Tiny booties, frequent feedings and diaper changes, sleep adjustments and more are highlighted with warm snuggles, gentle kisses and family bonding time. But for the Sundquist-Koch family, the happiness associated with those first few days as a new family took a sharp and unexpected turn soon after their son August Koch arrived home from the hospital. At the tender age of 2 weeks old, August spiked a fever and needed to be seen at Beverly Hospital’s pediatric emergency department. Fortunately for August (and his very nervous parents ...
Source: Thrive, Children's Hospital Boston - July 30, 2014 Category: Pediatrics Authors: Maureen McCarthy Tags: All posts Beverly Hospital our patients' stories Source Type: news

Featured in NEJM Journal Watch: Reducing Central Venous Catheter Infection Rates (FREE)
By the NEJM Journal Watch Editors Care … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 5, 2014 Category: Primary Care Source Type: news

There is No Such Thing As A Safe Execution
Never mind all that talk about Oklahoma’s botched execution of Clayton Lockett, who was supposed to be put to death yesterday by lethal injection, and instead died of a massive heart attack when one of the lines running into his arm blew out, causing the vein to rupture. He’s dead, ain’t he? Job done. MoreOhio Ups Lethal-Injection Dosages After Controversial ExecutionMore Innocent People on Death Row Than Estimated: StudyMen Charged With Toppling Ancient Rock Formation Avoid Jail Time Huffington PostHere's An Updated Tally Of All The People Who Have Ever Died From A Marijuana Overdose Huffington PostWatch...
Source: TIME: Top Science and Health Stories - April 30, 2014 Category: Science Authors: Jeffrey Kluger Tags: Uncategorized botched execution Death Penalty John Wayne Gacy justice lethal injection life imprisonment Murder Oklahoma Source Type: news

Duration of Central Catheter Use Drives Risk of Bloodstream Infections in Newborns - 11/11/13
A new study led by Johns Hopkins Children’s Center investigators shows that clinicians can reduce the risk of dangerous bloodstream infections in newborns with central venous catheters by ending use of the device as soon as possible, rather than waiting for signs of infection. (Source: Johns Hopkins Medicine News)
Source: Johns Hopkins Medicine News - November 11, 2013 Category: Research Source Type: news

Methods of delivering chemotherapy compared
A project funded by the NIHR HTA Programme is comparing the clinical and cost-effectiveness of three devices used to deliver chemotherapy.Chemotherapy can be delivered intravenously either through a cannula or by central venous devices such as subcutaneously tunnelled central catheters (Hickman type device), peripheral inserted central catheters (PICC) or implantable chest wall ports (Port).... (Source: NIHR Evaluation, Trials and Studies News)
Source: NIHR Evaluation, Trials and Studies News - September 26, 2013 Category: American Health Source Type: news

What is the Criteria for Diagnosing Beçhet’s disease?
Discussion Beçhet’s disease (BD) is a multisystem vasculitis named for the Turkish dermatologist, Hulusi Beçhet. It has a prevalance in one study of 5.2-7.1 per 100,000 adults. It is more common in males than females but it depends on the cohort studied and there is variation among different ancestral groups. Venous vasculitis usually causes thrombotic events whereas arterial vasculitis causes aneurysms and thrombosis. Involvement of the central nervous system vasculature can be a major problem. Central venous thrombosis can cause isolated intracranial hypertension but also aphasia, hemiparesis and sei...
Source: PediatricEducation.org - August 12, 2013 Category: Pediatrics Authors: Donna M. D'Alessandro, M.D. Tags: Uncategorized Source Type: news

Central Venous Catheters
Central venous catheters are used to give long-term intravenous chemotherapy. CVCs - look like PICC lines but are different. These catheters are good for patients who don't like to get stuck with needles. Learn more about central venous catheters here. (Source: About.com Breast Cancer)
Source: About.com Breast Cancer - July 2, 2013 Category: Cancer & Oncology Authors: breastcancer.guide at about.com Tags: health Source Type: news

Confusion increases risk of preventable errors
ST. LOUIS, June 25 (UPI) -- Retention of guidewires used to place central venous catheters is a preventable complication but nevertheless still happens, U.S. researchers say. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 25, 2013 Category: Consumer Health News Source Type: news

Reports Of Retained Guidewires Draw Attention To 'Never Events' In Anesthesia
Retention of guidewires used to place central venous catheters (CVCs) is a complication that is considered always preventable - but nevertheless still happens, according to a report in the July issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS). Dr Andrea Vannucci and colleagues report their hospital's experience of four patients with retained guidewires, and analyze risk factors for these rare, preventable medical errors... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 24, 2013 Category: Consumer Health News Tags: Pain / Anesthetics Source Type: news

Reports of retained guidewires draw attention to 'never events' in anesthesia
(Wolters Kluwer Health) Retention of guidewires used to place central venous catheters is a complication that is considered always preventable -- but nevertheless still happens, according to a report in the July issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 20, 2013 Category: Global & Universal Source Type: news

PICCS May Double Risk for Clots in Critically Ill Patients PICCS May Double Risk for Clots in Critically Ill Patients
PICCs are commonly used for the delivery of antibiotics, chemotherapy, and nutrition, and yet they may be more dangerous than central venous catheters. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 20, 2013 Category: Consumer Health News Tags: Critical Care News Source Type: news

BiO2 Medical's IDE Application for the Angel(TM) Catheter Receives FDA Approval
SAN ANTONIO, May 1, 2013 -- (Healthcare Sales & Marketing Network) -- BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, is among the first... Devices, FDABiO2 Medical, Angel Catheter, Vena Cava Filter, Central Venous Catheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 1, 2013 Category: Pharmaceuticals Source Type: news